Kolon Life Science Inc. (KOSDAQ:102940)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,380
+780 (5.00%)
Aug 10, 2026, 3:30 PM KST

Kolon Life Science Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9,60910,63612,4987,5616,37127,800
Short-Term Investments
-----110
Cash & Short-Term Investments
9,60910,63612,4987,5616,37127,910
Cash Growth
29.61%-14.90%65.29%18.68%-77.17%85.69%
Accounts Receivable
34,64337,20536,69924,60529,44019,649
Other Receivables
38.93216.611,0941,008302.04638.16
Receivables
34,68237,42137,79425,61329,74220,287
Inventory
65,29656,23646,72667,77768,49445,998
Prepaid Expenses
4,5603,3354,1273,4064,5793,743
Other Current Assets
781.78406.65909.02688.31998.1682.57
Total Current Assets
114,929108,035102,055105,045110,18498,021
Property, Plant & Equipment
133,247132,183115,076123,138125,960131,481
Long-Term Investments
894,658668,317197,22377,05475,2402,549
Goodwill
----1,2171,217
Other Intangible Assets
963.631,027554.34168.2858.9599.11
Long-Term Accounts Receivable
-00-00-0-0
Long-Term Deferred Charges
-1.544.86164.25283.64403.04
Other Long-Term Assets
4,6714,8504,6103,8661,174888.54
Total Assets
1,148,469914,413419,563309,436314,118234,658

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13,71412,93011,9507,44217,04913,774
Accrued Expenses
3,5645,0574,9084,3553,5943,145
Short-Term Debt
99,37392,155105,89097,26269,46159,064
Current Portion of Long-Term Debt
9,9904,9969,993-4,0005,333
Current Portion of Leases
861.3628.43692.76428.66287.62336.45
Current Income Taxes Payable
138.23599.13--376.36-
Current Unearned Revenue
3,2013,2013,2013,2013,2013,500
Other Current Liabilities
27,35850,21669,62015,65311,60810,316
Total Current Liabilities
158,199169,783206,255128,341109,57895,469
Long-Term Debt
-4,9908,6999,980-4,000
Long-Term Leases
1,160960.431,324191.33167.18191.02
Pension & Post-Retirement Benefits
-3,4986,8316,4399,81210,449
Long-Term Deferred Tax Liabilities
188,717138,95433,6299,8749,760-
Other Long-Term Liabilities
16,26212,19613,48716,93817,07825,139
Total Liabilities
364,338330,382270,225171,764146,395135,248

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
6,5456,4546,2125,7065,7065,706
Additional Paid-In Capital
211,010208,233192,801167,553209,114209,542
Retained Earnings
-182,695-203,380-228,091-133,289-101,537-106,024
Treasury Stock
------812.88
Comprehensive Income & Other
749,270572,724178,41797,70254,440-9,001
Shareholders' Equity
784,131584,030149,338137,672167,72399,410
Total Liabilities & Equity
1,148,469914,413419,563309,436314,118234,658

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
111,384103,730126,598107,86373,91668,925
Net Cash (Debt)
-101,776-93,094-114,100-100,301-67,545-41,015
Net Cash Growth
------
Net Cash Per Share
-6964.64-6496.63-9553.48-8788.83-5344.94-3597.74
Filing Date Shares Outstanding
13.0912.9112.4211.4111.4111.4
Total Common Shares Outstanding
13.0912.9112.4211.4111.4111.4
Working Capital
-43,270-61,748-104,200-23,296606.752,552
Book Value Per Share
59900.3045248.7112020.6812063.4114696.648720.06
Tangible Book Value
783,167583,003148,783137,504166,44898,094
Tangible Book Value Per Share
59826.6945169.1411976.0512048.6714584.868604.64
Land
16,31616,31616,28116,28117,28617,008
Buildings
63,35386,46881,46288,06988,56788,891
Machinery
34,584123,620108,063104,638101,589102,952
Construction In Progress
16,95918,05613,85717,81016,47415,952